ArticleFrontiers in immunology2026

Anlotinib plus PD-1 inhibitor in advanced soft tissue sarcoma: a real-world study on treatment patterns and treatment-emergent hypothyroidism.

Fang Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.